These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23882704)

  • 1. Commentaire de travail de Zhu YQ et al., pp. 458.
    Endoscopy; 2013 Jun; 45(6):594. PubMed ID: 23882704
    [No Abstract]   [Full Text] [Related]  

  • 2. Biodegradable rapamycin-eluting nano-fiber membrane-covered metal stent placement to reduce fibroblast proliferation in experimental stricture in a canine model.
    Zhu YQ; Cui WG; Cheng YS; Chang J; Chen NW; Yan L; Li MH
    Endoscopy; 2013 Jun; 45(6):458-68. PubMed ID: 23580413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporary placement of a paclitaxel or rapamycin-eluting stent is effective to reduce stenting induced inflammatory reaction and scaring in benign cardia stricture models.
    Wang L; Zhu YQ; Cheng YS; Cui WG; Chen NW
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():69-74. PubMed ID: 25910372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very late stent fracture associated with a sirolimus-eluting stent.
    Leong DP; Dundon BK; Puri R; Yeend RA
    Heart Lung Circ; 2008 Oct; 17(5):426-8. PubMed ID: 17728185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-eluting stents. (The results of the five-year use for the treatment of coronary artery disease).
    Krylov AL
    Angiol Sosud Khir; 2006; 12(4):71-82. PubMed ID: 17679960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.
    Orvin K; Carrie D; Richardt G; Desmet W; Assali A; Werner G; Ikari Y; Fujii K; Goicolea J; Dangoisse V; Manari A; Saito S; Wijns W; Kornowski R
    Catheter Cardiovasc Interv; 2016 May; 87(6):1092-100. PubMed ID: 26268482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of New Sirolimus-eluting Stent Models in a Preclinical Study.
    Estévez-Loureiro R; Pérez de Prado A; Pérez-Martínez C; Cuellas-Ramón C; Regueiro-Purriños M; Gonzalo-Orden JM; López-Benito M; Molina-Crisol M; Duocastella-Codina L; Fernández-Vázquez F
    Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1118-24. PubMed ID: 26206247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very late sirolimus-eluting stent thrombosis due to stent fracture and late-acquired incomplete stent apposition detected on multislice computed tomography.
    Ito T; Terashima M; Kaneda H; Nasu K; Kinoshita Y; Habara M; Tsuchikane E; Suzuki T
    Circ J; 2011; 75(11):2716-7. PubMed ID: 21799268
    [No Abstract]   [Full Text] [Related]  

  • 10. Propensity-Score Matched Comparison of Midterm Angiographic Outcomes of Sirolimus- Versus Everolimus- and Biolimus-Eluting Stents for De Novo Coronary Stenosis.
    Suzuki K; Ishikawa T; Mutoh M; Sakamoto H; Mori C; Ogawa T; Hashimoto K; Kubota T; Komukai K; Yoshimura M;
    Int Heart J; 2017 May; 58(3):320-327. PubMed ID: 28484124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neointimal reaction in overlap segments of drug-eluting stents: is it "one-size-fits-all"?
    Nammas W
    Am Heart J; 2013 Oct; 166(4):e29. PubMed ID: 24093867
    [No Abstract]   [Full Text] [Related]  

  • 13. Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.
    Sinning JM; Baumgart D; Werner N; Klauss V; Baer FM; Hartmann F; Drexler H; Motz W; Klues H; Voelker W; Pfannebecker T; Stoll HP; Nickenig G;
    Am Heart J; 2012 Mar; 163(3):446-53, 453.e1. PubMed ID: 22424016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroscopically guided insertion of self-expandable metal esophageal stents for palliative treatment of patients with malignant stenosis of esophagus and cardia: comparison of uncovered and covered stent types.
    Saranovic Dj; Djuric-Stefanovic A; Ivanovic A; Masulovic D; Pesko P
    Dis Esophagus; 2005; 18(4):230-8. PubMed ID: 16128779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin inhibits human laryngotracheal stenosis-derived fibroblast proliferation, metabolism, and function in vitro.
    Namba DR; Ma G; Samad I; Ding D; Pandian V; Powell JD; Horton MR; Hillel AT
    Otolaryngol Head Neck Surg; 2015 May; 152(5):881-8. PubMed ID: 25754184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents.
    Bonello L; Buch AN; De Labriolle A; Roy P; Steinberg DH; Pinto Slottow TL; Kaneshige K; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Int J Cardiol; 2010 Sep; 144(1):105-7. PubMed ID: 19201042
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell viability of fibroblasts to pifenidone and sirolimus: a future concept for drug eluting stents.
    Walter RF; Zarogoulidis P; Mairinger FD; Werner R; Darwiche K; Zarogoulidis K; Freitag L
    Int J Pharm; 2014 May; 466(1-2):38-43. PubMed ID: 24607204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms explaining the late "catch-up" phenomenon after sirolimus-eluting stent implantation.
    Tajiri K; Sato A; Hoshi T; Kimura T; Nakagawa Y; Sakai S; Aonuma K; Watanabe S
    Int J Cardiol; 2014 Nov; 177(1):44-5. PubMed ID: 25499335
    [No Abstract]   [Full Text] [Related]  

  • 19. Exaggerated inflammatory response following sirolimus-eluting stent fracture.
    Belardi JA; Padilla LT; Cura FA; Nau G; Candiello A; Ronderos R; Albertal M
    Int J Cardiol; 2011 Sep; 151(2):e45-6. PubMed ID: 20510471
    [No Abstract]   [Full Text] [Related]  

  • 20. Early experience of transradial multivessel percutaneous coronary intervention with new generation STENTYS sirolimus eluting self-apposing stents for ectatic coronary arteries.
    Yew KL
    Int J Cardiol; 2015 Apr; 185():155-6. PubMed ID: 25795209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.